Irish Independent – Open Orphan signs ‘significant’ revenue generating contract

by Ellie Donnelly Open Orphan, a Europe-focused pharma services company specialising in rare disease and so-called orphan drugs, has signed a contract with a German-based research-driven pharmaceutical company. Open Orphan said the contract guarantees “significant” annual income, with work under the deal to commence this month. This contract will see Venn Life Sciences, part of […]

Open Orphan #ORPH – New 3 Year Contract with major Pharmaceutical Company

Open Orphan, a European-focussed, rare and orphan drug consulting services platform, is pleased to announce the signing of a new 3-year contract with a tier 1 German pharmaceutical company which is one of Europe’s top research-driven pharmaceutical companies. The contract guarantees significant annual revenue with work under the contract to commence this month. This contract sees Venn Life Sciences […]

Open Orphan #ORPH – New Contract with SFA Therapeutics

Open Orphan, a European-focussed, rare and orphan drug consulting services platform, is pleased to announce the signing of a contract with SFA Therapeutics, a biopharmaceutical company based in Pennsylvania, USA (“SFA Therapeutics”). This contract sees Venn Life Sciences (“Venn”), part of Open Orphan plc, provide SFA Therapeutics with assistance in the filing of a European Medicines Agency […]

Ian Pollard – Blame The Headwinds, Not The Management

ConvaTec Geoup CTE admits to a disappointing performance in 2017 due to unspecified headwinds and significant challenges, the nature of which are not disclosed..Supply constraints from which it suffered during the year will continue to have an impact in 2018, especially in the first half due to back order fulfillment and lost orders. Revenue for […]